BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2695154)

  • 1. Characteristics of persistent ovarian masses in asymptomatic women.
    Bhan V; Amso N; Whitehead MI; Campbell S; Royston P; Collins WP
    Br J Obstet Gynaecol; 1989 Dec; 96(12):1384-91. PubMed ID: 2695154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transabdominal ultrasound screening for early ovarian cancer.
    Campbell S; Bhan V; Royston P; Whitehead MI; Collins WP
    BMJ; 1989 Dec; 299(6712):1363-7. PubMed ID: 2513964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel screening strategies for early ovarian cancer by transabdominal ultrasonography.
    Campbell S; Royston P; Bhan V; Whitehead MI; Collins WP
    Br J Obstet Gynaecol; 1990 Apr; 97(4):304-11. PubMed ID: 2187523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound screening for familial ovarian cancer.
    Bourne TH; Whitehead MI; Campbell S; Royston P; Bhan V; Collins WP
    Gynecol Oncol; 1991 Nov; 43(2):92-7. PubMed ID: 1743564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer.
    Bourne T; Campbell S; Steer C; Whitehead MI; Collins WP
    BMJ; 1989 Dec; 299(6712):1367-70. PubMed ID: 2513965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
    Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
    Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
    Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
    Bourne TH; Campbell S; Reynolds KM; Whitehead MI; Hampson J; Royston P; Crayford TJ; Collins WP
    BMJ; 1993 Apr; 306(6884):1025-9. PubMed ID: 8490496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaginal ultrasound as a screening method for detection of adnexa tumors in postmenopause?].
    Osmers R; Völksen M; Rath W; Kuhn W
    Onkologie; 1990 Aug; 13(4):268-70. PubMed ID: 2234779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian status in healthy postmenopausal women.
    Healy DL; Bell R; Robertson DM; Jobling T; Oehler MK; Edwards A; Shekleton P; Oldham J; Piessens S; Teoh M; Mamers P; Taylor N; Walker F
    Menopause; 2008; 15(6):1109-14. PubMed ID: 18536617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
    Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound.
    Vuento MH; Pirhonen JP; Mäkinen JI; Laippala PJ; Grönroos M; Salmi TA
    Cancer; 1995 Oct; 76(7):1214-8. PubMed ID: 8630900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumes of normal ovaries, ovaries with benign lesions, and ovaries with cancer in menopausal women: is there an optimal cut-off value to predict malignancy?
    Aviram R; Gassner G; Markovitch O; Cohen I; Fishman A; Tepper R
    J Clin Ultrasound; 2008 Jan; 36(1):1-5. PubMed ID: 17924576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of transvaginal sonography for evaluation of postmenopausal ovarian size and morphology.
    Rodriguez MH; Platt LD; Medearis AL; Lacarra M; Lobo RA
    Am J Obstet Gynecol; 1988 Oct; 159(4):810-4. PubMed ID: 3052076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography--study on size of ovary to select subjects requiring second screening].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1173-9. PubMed ID: 1453046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective evaluation of transvaginal sonography for detection of ovarian disease.
    DiSantis DJ; Scatarige JC; Kemp G; Given FT; Hsiu JG; Cramer MS
    AJR Am J Roentgenol; 1993 Jul; 161(1):91-4. PubMed ID: 8517330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.
    Jacobs I; Davies AP; Bridges J; Stabile I; Fay T; Lower A; Grudzinskas JG; Oram D
    BMJ; 1993 Apr; 306(6884):1030-4. PubMed ID: 8490497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
    van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different features of the histopathological subtypes of ovarian tumors in pre- and postmenopausal women.
    Jung EJ; Eom HM; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Jeong DH
    Menopause; 2017 Sep; 24(9):1028-1032. PubMed ID: 28832426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.